Type B Insulin-resistance syndrome: a cause of reversible autoimmune hypoglycaemia.
Assistance Publique-Hôpitaux de Paris, Department of Endocrinology, Nutrition, and Diabetes, Paris, France; Sorbonne Universités, Paris, France; INSERM UMR_S 1138 Centre de recherche des Cordeliers, Paris, France; Institute of Cardiometabolism and Nutrition, Paris, France. Electronic address: olivier.bourron@psl.aphp.fr.
Olivier
O
Bourron
Sorbonne Universités, Paris, France; INSERM UMR_S 938 Saint-Antoine Research Centre, Paris, France; Institute of Cardiometabolism and Nutrition, Paris, France.
Martine
M
Caron-Debarle
Department of Internal Medicine, Pitié-Salpêtrière Hospital, Paris, France; Sorbonne Universités, Paris, France.
Miguel
M
Hie
Department of Internal Medicine, Pitié-Salpêtrière Hospital, Paris, France; Sorbonne Universités, Paris, France.
Zahir
Z
Amoura
Assistance Publique-Hôpitaux de Paris, Department of Endocrinology, Nutrition, and Diabetes, Paris, France; Sorbonne Universités, Paris, France; Institute of Cardiometabolism and Nutrition, Paris, France.
Fabrizio
F
Andreelli
Assistance Publique-Hôpitaux de Paris, Department of Endocrinology, Nutrition, and Diabetes, Paris, France; Institute of Cardiometabolism and Nutrition, Paris, France.
Marine
M
Halbron
Department of Biochemistry, Pitié-Salpêtrière Hospital, Paris, France.
Michelle
M
Fonfrede
Department of Internal Medicine, Pitié-Salpêtrière Hospital, Paris, France.
Gaëlle
G
Leroux
Department of Molecular Biology, Saint-Antoine Hospital, Paris, France; Sorbonne Universités, Paris, France; INSERM UMR_S 938 Saint-Antoine Research Centre, Paris, France; Institute of Cardiometabolism and Nutrition, Paris, France.
Corinne
C
Vigouroux
Assistance Publique-Hôpitaux de Paris, Department of Endocrinology, Nutrition, and Diabetes, Paris, France; Sorbonne Universités, Paris, France; INSERM UMR_S 1138 Centre de recherche des Cordeliers, Paris, France; Institute of Cardiometabolism and Nutrition, Paris, France.
Agnès
A
Hartemann
D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy / Q000209:etiology*; D007155:Immunologic Factors / Q000627:therapeutic use; D007333:Insulin Resistance / Q000502:physiology*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008297:Male; D011972:Receptor, Insulin / Q000276:immunology; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D007155:Immunologic Factors; D000069283:Rituximab; D011972:Receptor, Insulin